T. Rowe Price Associates’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$816K Buy
47,001
+7,783
+20% +$147K ﹤0.01% 2242
2025
Q4
$739K Buy
39,218
+711
+2% +$11.9K ﹤0.01% 2216
2025
Q3
$560K Buy
38,507
+3,964
+11% +$56.5K ﹤0.01% 2317
2025
Q2
$675K Buy
34,543
+5,124
+17% +$91K ﹤0.01% 2158
2025
Q1
$523K Buy
29,419
+2,303
+8% +$49.6K ﹤0.01% 2240
2024
Q4
$581K Buy
27,116
+3,016
+13% +$73.4K ﹤0.01% 2226
2024
Q3
$753K Sell
24,100
-6,031
-20% -$150K ﹤0.01% 2079
2024
Q2
$468K Buy
30,131
+735
+3% +$8.88K ﹤0.01% 2217
2024
Q1
$312K Buy
29,396
+2,344
+9% +$23.4K ﹤0.01% 2417
2023
Q4
$325K Sell
27,052
-15,937
-37% -$131K ﹤0.01% 2347
2023
Q3
$301K Buy
42,989
+6,839
+19% +$63.2K ﹤0.01% 2334
2023
Q2
$308K Buy
36,150
+4,640
+15% +$38.7K ﹤0.01% 2352
2023
Q1
$289K Sell
31,510
-236,291
-88% -$3.02M ﹤0.01% 2361
2022
Q4
$3.06M Sell
267,801
-139,962
-34% -$2.07M ﹤0.01% 1315
2022
Q3
$6.94M Sell
407,763
-682
-0.2% -$14.6K ﹤0.01% 1137
2022
Q2
$8.77M Sell
408,445
-323,737
-44% -$8.98M ﹤0.01% 1341
2022
Q1
$27.1M Sell
732,182
-116,631
-14% -$4.55M ﹤0.01% 1152
2021
Q4
$38.6M Buy
848,813
+77,404
+10% +$4.04M ﹤0.01% 1089
2021
Q3
$48.9M Sell
771,409
-8,428
-1% -$642K ﹤0.01% 1018
2021
Q2
$71.4M Sell
779,837
-22,989
-3% -$1.83M 0.01% 909
2021
Q1
$54.7M Sell
802,826
-615,515
-43% -$47.8M 0.01% 971
2020
Q4
$103M Buy
1,418,341
+65,135
+5% +$3.77M 0.01% 719
2020
Q3
$51.3M Sell
1,353,206
-482,112
-26% -$16.3M 0.01% 862
2020
Q2
$65M Buy
1,835,318
+1,695,800
+1,215% +$48.3M 0.01% 763
2020
Q1
$3.05M Buy
+139,518
New +$3.13M ﹤0.01% 1413
2019
Q4
Sell
-160,889
Closed -$3.64M 2532
2019
Q3
$3.64M Sell
160,889
-305,329
-65% -$8.46M ﹤0.01% 1427
2019
Q2
$16.8M Buy
466,218
+60,500
+15% +$1.94M ﹤0.01% 1226
2019
Q1
$12.8M Buy
405,718
+85,030
+27% +$2.48M ﹤0.01% 1282
2018
Q4
$8.06M Buy
+320,688
New +$8.24M ﹤0.01% 1339
2015
Q3
Sell
-16,504
Closed -$107K 2517
2015
Q2
$107K Sell
16,504
-11,231
-40% -$61K ﹤0.01% 2452
2015
Q1
$154K Buy
+27,735
New +$183K ﹤0.01% 2411

Other funds holding CDNA